Latest Regulatory News

Equinox Resources updates on ongoing judicial review concerning Aboriginal site boundary uncertainties at its Hamersley Iron Ore Project, with court deadlines extended and a final hearing expected by year-end.

BPM Minerals is set to launch its first reverse circulation drilling campaign at the Forelands Gold Project in Western Australia, targeting the promising Beachcomber Prospect. The program aims to unlock a major gold system with results expected early next year.

Aura Energy announces the immediate resignation of Managing Director Andrew Grove, with Executive Chair Philip Mitchell stepping in to manage operations during critical funding talks. The company remains focused on advancing its uranium and polymetallic projects in Mauritania and Sweden.

Viridis Mining and Minerals has secured a prime site and finalized key contracts for its Rare Earth Research and Processing Centre in Brazil, positioning itself as a critical Western-aligned rare earth supplier amid tightening Chinese export controls.

Bayan Mining and Minerals has made significant strides at its Desert Star Projects in California, including key technical appointments, regulatory approvals, and preparations for maiden drilling. Positioned near major rare earth and gold mines, the projects reaffirm their potential to contribute to North America's critical minerals supply chain.

Immutep’s novel immunotherapy combination with KEYTRUDA and chemotherapy shows promising response rates in first line non-small cell lung cancer, especially in patients with low or no PD-L1 expression.

Ardea Resources has extended its Major Project Status for the Kalgoorlie Nickel Project, reinforcing its strategic role in Australia's critical minerals sector and ensuring continued government support.

Immutep Limited’s Phase II trial of eftilagimod alfa combined with radiotherapy and KEYTRUDA in soft tissue sarcoma patients has exceeded its primary endpoint, showing a 51.5% median tumor hyalinization rate, more than triple the historical standard. These promising results, presented at ESMO 2025, suggest a potential breakthrough in a challenging cancer indication.

Vectus Biosystems has agreed to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics for US$3 million in shares and warrants, gaining a strategic equity position while refocusing on its cardiovascular and fibrosis pipeline.

BlackRock Investment Management (Australia) Limited has announced final cash distributions for its iShares Balanced ESG ETF and High Growth ESG ETF, detailing payment schedules and reinvestment options for investors.

Vault Minerals Limited has announced a significant security consolidation, reducing its ordinary shares and performance rights by a factor of more than six. The move, effective from mid-November, aims to streamline the company’s capital structure ahead of resumed trading.

Prominence Energy has achieved a pivotal milestone with the award of Petroleum Exploration Licence 803 for its Gawler Hydrogen Project, positioning itself as a key player in Australia's emerging natural hydrogen sector. The company also strengthened its leadership team and completed a $1.75 million capital raise to fund its growth ambitions.